ENTITY

Actuate Therapeutics (ACTU US)

2
Analysis
Health Care • United States
Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). The company is developing elraglusib, an ATP-competitive small molecule designed to block the function of GSK-3β, which is a master regulator of complex biological signaling cascades that lead to tumor cell survival, growth, migration, and invasion.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x